The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

Overall Organization of DSM-5 | Neurodevelopmental Disorders | Schizophrenia Spectrum and Other Psychotic Disorders | Mood Disorders | Anxiety Disorders | Obsessive-Compulsive and Related Disorders | Trauma- and Stressor-Related Disorders | Somatic Symptom and Related Disorders | Personality Disorders | Substance Use Disorders | Feeding and Eating Disorders | FDA Approval of Symptom Reduction Strategies | DSM-5 and Genetics | Summary | Bibliography

Excerpt

Since the late 1970s, psychiatry has paid greater attention to rigorous diagnosis and classification, as evidenced by the 1980 publication of the then forward-thinking DSM-III (American Psychiatric Association 1980). Unlike earlier editions, DSM-III provided detailed diagnostic criteria and descriptive diagnoses. Subsequent editions, including DSM-III-R (American Psychiatric Association 1987), DSM-IV (American Psychiatric Association 1994) (the text revision of which, DSM-IV-TR, was published in 2000; American Psychiatric Association 2000), and most recently DSM-5 (American Psychiatric Association 2013), refined these diagnostic criteria. They have made changes primarily on the basis of new empirical data and the results of field trials. Over the years, much of the attention to more rigorous nosology had been sparked by advances in the biology and treatment of various psychiatric disorders, making precise diagnosis seemingly ever more important. For example, the response to lithium carbonate of many patients diagnosed as having bipolar (manic-depressive) illness fostered diligent efforts to discriminate between manic-depressive illness and schizophrenia, which resulted in a change of diagnosis for many patients and alterations in their treatment. However, diagnostic precision does not always lead to clear and effective treatment.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).